Ionis Pharmaceuticals Files 8-K on Financials
Ticker: IONS · Form: 8-K · Filed: Jul 30, 2025 · CIK: 874015
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
IONIS filed an 8-K on 7/30/25 detailing financial condition and results.
AI Summary
Ionis Pharmaceuticals, Inc. filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company incorporated in Delaware and headquartered in Carlsbad, CA.
Why It Matters
This 8-K filing provides investors with crucial updates on Ionis Pharmaceuticals' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- IONIS PHARMACEUTICALS, INC. (company) — Registrant
- July 30, 2025 (date) — Date of report
- Carlsbad, CA (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Ionis Pharmaceuticals, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on July 30, 2025.
Where is Ionis Pharmaceuticals, Inc. headquartered?
Ionis Pharmaceuticals, Inc.'s principal executive offices are located at 2855 Gazelle Court, Carlsbad, CA 92010.
In which state was Ionis Pharmaceuticals, Inc. incorporated?
Ionis Pharmaceuticals, Inc. was incorporated in Delaware.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 33-0336973.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).